Covista stock analysis
Covista (CVSA) Stock Price & Analysis
CVSA Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- CHF 3.01B
- Enterprise Value
- CHF 4.74B
- Total Cash (Recent Filing)
- CHF 222.22M
- Total Debt (Recent Filing)
- CHF 753.59M
- Price to Earnings (P/E)
- 14.4
- Beta
- N/A
- Next Earnings
- Feb 02, 2027 (Est.)
- EPS Estimate
- 1.79
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Profitability Growth
The shift from a 2022 loss to consistently positive earnings, alongside revenue growth to $2.00 billion, demonstrates materially improved operating performance. Healthy TTM operating and EBITDA margins provide an earnings base that can support continued investment and strengthen financial resilience over the next several quarters.
Enrollment Expansion And Healthcare Demand
Broad-based enrollment growth across all three segments indicates sustained demand for Covista’s education offerings rather than reliance on a single program. The extended streak of growth, supported by healthcare labor shortages and capacity constraints, can reinforce revenue visibility over the medium term.
Cash Generation And Leverage
Strong free cash flow and low net leverage give Covista meaningful flexibility to fund campuses, technology, and employer programs while continuing shareholder returns. This combination reduces balance-sheet strain and supports growth investment without requiring a substantial increase in financial risk.
Bears Say
Gross Margin Pressure
The sharp reduction in gross margin relative to prior annual levels signals cost pressure or an unfavorable mix shift that could limit earnings conversion if it persists. Although operating profitability remains healthy, sustained gross-margin compression would make future profit growth more dependent on volume and efficiency gains.
Chamberlain Enrollment Execution
Chamberlain’s slower enrollment growth creates an execution risk within a major operating segment, particularly as new campuses require investment before reaching meaningful scale. Continued weakness among returning and postlicensure students could moderate consolidated growth and delay the payoff from expansion.
Variable Cash Conversion
Positive cash generation remains a strength, but the recent decline in free cash flow and historically uneven cash conversion indicate that reported earnings may not translate consistently into deployable cash. Working-capital variability could constrain funding flexibility during periods of heavier campus and technology spending.
Covista News
CVSA FAQ
What is Covista’s market cap?
When is Covista’s upcoming earnings report date?
How were Covista’s earnings last quarter?
Is Covista overvalued?
Does Covista pay dividends?
What is Covista’s EPS estimate?
What happened to Covista’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Covista?
What is the TipRanks Smart Score and how is it calculated?
Covista Stock Smart Score
Company Description
Covista
Covista Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.
- Sector
- Consumerdefensive
- Industry
- Education & Training Services
- CEO
- Stephen W. Beard
- Employees
- 4,754
- Website
- www.covista.com
- Address
- 233 South Wacker Drive, Chicago, IL, 60606, US
Covista (CVSA) Earnings & Revenues
CVSA Company Deck
CVSA Earnings Call
Earnings Call SentimentPositive
The call was strongly positive. Covista reported double-digit revenue, EBITDA, net income, and EPS growth; continued company-wide enrollment gains; record Walden enrollment; strong medical and veterinary profitability; robust free cash flow; and raised fiscal 2027 revenue and EPS guidance. The main challenges were slower-than-expected Chamberlain enrollment, campus startup investments, medical-school financing hesitancy, quarterly calendar effects, a higher tax rate, and the announced CFO transition.
View all CH:CVSA earnings summaries






